Home/Filings/4/0001437749-25-034919
4//SEC Filing

Ussery Robert Michael 4

Accession 0001437749-25-034919

CIK 0001047335other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 5:51 PM ET

Size

14.7 KB

Accession

0001437749-25-034919

Insider Transaction Report

Form 4
Period: 2025-11-11
Ussery Robert Michael
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2025-11-11$132.20/sh3,720$491,784161,523 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    2025-11-114,5004,500 total
    Exercise: $53.94From: 2024-03-08Exp: 2028-03-08Common Stock (9,000 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock

    2025-11-114,5009,000 total
    Exercise: $94.10From: 2025-03-05Exp: 2029-03-05Common Stock (13,500 underlying)
  • Exercise/Conversion

    Common Stock

    2025-11-11$53.94/sh+4,500$242,730162,448 total
  • Exercise/Conversion

    Common Stock

    2025-11-11$94.10/sh+4,500$423,450165,243 total
  • Tax Payment

    Common Stock

    2025-11-11$132.20/sh1,705$225,401160,743 total
Holdings
  • Option to Purchase Common Stock

    Exercise: $90.62From: 2026-02-24Exp: 2030-02-24Common Stock (15,000 underlying)
    15,000
Footnotes (4)
  • [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F2]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F3]Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
  • [F4]Total amount of shares beneficially owned following transactions reported on this form.

Issuer

NATIONAL HEALTHCARE CORP

CIK 0001047335

Entity typeother

Related Parties

1
  • filerCIK 0001313364

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:51 PM ET
Size
14.7 KB